SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4

BACKGROUND: Renal tubulointerstitial fibrosis is the hallmark of various chronic kidney diseases. Symmetric dimethylarginine (SDMA) is an independent cardiovascular risk factor in patients with chronic kidney diseases, which is mostly excreted through renal tubules. However, the effect of SDMA on ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanzhe, Wu, Ming, Chen, Dongping, Tan, Bo, Lin, Pinglan, Huang, Di, Ye, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186707/
https://www.ncbi.nlm.nih.gov/pubmed/37194066
http://dx.doi.org/10.1186/s12967-023-04181-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186707/
https://www.ncbi.nlm.nih.gov/pubmed/37194066
http://dx.doi.org/10.1186/s12967-023-04181-9

Ejemplares similares